Equities

Tandem Diabetes Care Inc

Tandem Diabetes Care Inc

Actions
  • Price (EUR)39.50
  • Today's Change1.37 / 3.59%
  • Shares traded10.00
  • 1 Year change+91.01%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments468617624
Total Receivables, Net106115111
Total Inventory15811169
Prepaid expenses177.248.43
Other current assets, total------
Total current assets748850812
Property, plant & equipment, net16417978
Goodwill, net------
Intangibles, net2.784.636.64
Long term investments------
Note receivable - long term------
Other long term assets38199.09
Total assets9531,053905
LIABILITIES
Accounts payable505628
Accrued expenses736170
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total724834
Total current liabilities195165132
Total long term debt285283281
Total debt285283281
Deferred income tax------
Minority interest------
Other liabilities, total15916459
Total liabilities639613472
SHAREHOLDERS EQUITY
Common stock0.070.070.06
Additional paid-in capital1,2641,1711,068
Retained earnings (accumulated deficit)(952)(729)(635)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total1.37(1.82)(0.62)
Total equity314440433
Total liabilities & shareholders' equity9531,053905
Total common shares outstanding666564
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.